Chen J - Search Results

1

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer.

Amato KR, Wang S, Tan L, Hastings AK, Song W, Lovly CM, Meador CB, Ye F, Lu P, Balko JM, Colvin DC, Cates JM, Pao W, Gray NS, Chen J. Amato KR, et al. Among authors: chen j. Cancer Res. 2016 Jan 15;76(2):305-18. doi: 10.1158/0008-5472.CAN-15-0717. Epub 2016 Jan 7. Cancer Res. 2016. PMID: 26744526 Free PMC article.

2

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J. Cheng N, et al. Among authors: chen j. Mol Cancer Res. 2002 Nov;1(1):2-11. Mol Cancer Res. 2002. PMID: 12496364

3

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Ireton RC, Chen J. Ireton RC, et al. Among authors: chen j. Curr Cancer Drug Targets. 2005 May;5(3):149-57. doi: 10.2174/1568009053765780. Curr Cancer Drug Targets. 2005. PMID: 15892616 Review.

4

A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

Fang WB, Brantley-Sieders DM, Parker MA, Reith AD, Chen J. Fang WB, et al. Among authors: chen j. Oncogene. 2005 Nov 24;24(53):7859-68. doi: 10.1038/sj.onc.1208937. Oncogene. 2005. PMID: 16103880

5

Inhibition of retinal neovascularization by soluble EphA2 receptor.

Chen J, Hicks D, Brantley-Sieders D, Cheng N, McCollum GW, Qi-Werdich X, Penn J. Chen J, et al. Exp Eye Res. 2006 Apr;82(4):664-73. doi: 10.1016/j.exer.2005.09.004. Epub 2005 Dec 15. Exp Eye Res. 2006. PMID: 16359662

6

Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J. Brantley-Sieders DM, et al. Among authors: chen j. Cancer Res. 2006 Nov 1;66(21):10315-24. doi: 10.1158/0008-5472.CAN-06-1560. Cancer Res. 2006. PMID: 17079451

7

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J. Brantley-Sieders DM, et al. Among authors: chen j. J Clin Invest. 2008 Jan;118(1):64-78. doi: 10.1172/JCI33154. J Clin Invest. 2008. PMID: 18079969 Free PMC article.

8

Eph receptors and Ephrins in cancer: common themes and controversies.

Chen J, Zhuang G, Frieden L, Debinski W. Chen J, et al. Cancer Res. 2008 Dec 15;68(24):10031-3. doi: 10.1158/0008-5472.CAN-08-3010. Cancer Res. 2008. PMID: 19074866 Free PMC article. No abstract available.

9

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.

Vaught D, Brantley-Sieders DM, Chen J. Vaught D, et al. Among authors: chen j. Breast Cancer Res. 2008;10(6):217. doi: 10.1186/bcr2207. Epub 2008 Dec 22. Breast Cancer Res. 2008. PMID: 19144211 Free PMC article. Review.

10

Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase.

Vaught D, Chen J, Brantley-Sieders DM. Vaught D, et al. Among authors: chen j. Mol Biol Cell. 2009 May;20(10):2572-81. doi: 10.1091/mbc.e08-04-0378. Epub 2009 Mar 25. Mol Biol Cell. 2009. PMID: 19321667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,968 results

Search Page

Filters